Key result
BAV shows no difference in 10-year survival versus TAV in isolated aortic valve infective endocarditis.
Why the study?
Bicuspid aortic valve is associated with an increased risk of infective endocarditis, but few data are available on isolated native BAV-IE.
Does bicuspid aortic valve infective endocarditis alter mortality compared to tricuspid aortic valve infective endocarditis in patients with isolated native aortic valve IE?
Cohort (n=728)
Yes
Does bicuspid aortic valve infective endocarditis alter mortality compared to tricuspid aortic valve infective endocarditis in patients with isolated native aortic valve IE?
Absolute Event Rate: 73% vs 76%
p-value: p=0.91
While bicuspid aortic valve infective endocarditis presents with more perivalvular and neurological complications, long-term survival is comparable to tricuspid aortic valve endocarditis when matched for age and comorbidities.
Introduction Bicuspid aortic valve (BAV) is the most common congenital heart disease with an increased risk of infective endocarditis (IE). Few data are available on isolated native BAV-IE. The aim of this study was to compare patients with tricuspid aortic valve (TAV) IE and BAV-IE in terms of characteristics, management and prognosis. Material and methods We included 728 consecutive patients with IE on isolated native aortic valve in 3 centres: Amiens and Marseille Hospitals in France and Salerno Hospital in Italy. We studied in hospital and long-term mortality before and after matching for age, sex and comorbidity index. Median follow-up was 67.2 [IQR: 19–120] months. Results Of the 728 patients, 123 (16.9%) had BAV. Compared with patients with TAV-IE, patients with BAV-IE were younger, had fewer co-morbidities and were more likely to be male. They presented more major neurological events and perivalvular complications (both p < 0.05). Early surgery (<30 days) was performed in 52% of BAV-IE cases vs. 42.8% for TAV-IE (p = 0.061). The 10-year survival rate was 74 ± 5% in BAV-IE patients compared with 66 ± 2% in TAV-IE patients (p = 0.047). After propensity score matching (for age, gender and comorbidities), there was no difference in mortality between the two groups, with an estimated 10-year survival of 73 ± 5% vs. 76 ± 4% respectively (p = 0.91). Conclusion BAV is a frequent finding in patients with isolated aortic valve IE and is associated with more perivalvular complications and neurological events. The differences in survival with TAV-IE are probably related to the age and comorbidity differences between these two populations.
No takes yet. Share an insight, caveat, or question.
Bohbot et al. (2023) conducted a cohort in Isolated native aortic valve infective endocarditis (n=728). Bicuspid aortic valve vs. Tricuspid aortic valve was evaluated on 10-year survival (propensity-matched cohort) (p=0.91). In patients with isolated aortic valve infective endocarditis, bicuspid aortic valve was not associated with a difference in 10-year survival compared to tricuspid aortic valve after propensity matching (73% vs 76%, p=0.91).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: